Tonix Pharmaceuticals Holding Corp.
As of Oct 22, 2026, Tonix Pharmaceuticals Holding is in Stage 4, the downtrend phase, now in week 4 (since Sep 25, 2026). It closed at $5.13, 74.8% below its 52-week high and below its 200-day average, which is falling.
Tonix Pharmaceuticals Holding Corp., a fully integrated biopharmaceutical company, develops and commercializes therapies for central nervous system (CNS) disorders, immunology and immuno-oncology, inf… More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is TNXP early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
TNXP among Biotechnology435th of 591 by relative strength
All 591 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | GTBP | Stage 2 · wk 7 | 99 | −22.3% |
| 2 | IOVA | Stage 2 · wk 18 | 99 | +38.8% |
| 3 | SLS | Stage 3 · wk 4 | 99 | −1.5% |
| 4 | MRNA | Stage 2 · wk 17 | 99 | +11.3% |
| 5 | TWST | Stage 2 · wk 39 | 99 | −14.5% |
| 6 | KOD | Stage 2 · wk 4 | 99 | +172.1% |
| 7 | ERAS | Stage 3 · wk 5 | 99 | +0.7% |
| 8 | CLYM | Stage 3 · wk 3 | 99 | −15.8% |
| …435 | TNXP | Stage 4 · wk 4 | 14 | −49.9% |
Tonix Pharmaceuticals Holding: quick answers
What stage is Tonix Pharmaceuticals Holding in?
As of Oct 22, 2026, Tonix Pharmaceuticals Holding (TNXP) is in Stage 4, the downtrend phase. It entered Stage 4 on Sep 25, 2026 and is in week 4. What the four stages mean
Is Tonix Pharmaceuticals Holding in an uptrend?
No. Tonix Pharmaceuticals Holding is in a Stage 4 downtrend. It trades 59.9% below its 200-day average, which is falling.
How far is Tonix Pharmaceuticals Holding from its 52-week high?
Tonix Pharmaceuticals Holding closed at $5.13 on Oct 22, 2026, 74.8% below its 52-week high of $20.35. Its 52-week low is $5.13.
How has Tonix Pharmaceuticals Holding performed over the past year?
As of Oct 22, 2026, Tonix Pharmaceuticals Holding is down 74.0% over the past year and down 69.0% so far in 2026.
Which sector and industry is Tonix Pharmaceuticals Holding in?
Tonix Pharmaceuticals Holding is in the Biotechnology industry, part of the Health Care sector.
About this companyHealth Care· Biotechnology
Tonix Pharmaceuticals Holding Corp., a fully integrated biopharmaceutical company, develops and commercializes therapies for central nervous system (CNS) disorders, immunology and immuno-oncology, infectious diseases, and rare diseases in the United States. The company offers TONMYA, a cyclobenzaprine HCl sublingual tablet for the treatment of fibromyalgia. It also markets Zembrace SymTouch and Tosymra for the treatment of acute migraine with or without aura in adults. In addition, the company develops TNX-102 SL, a cyclobenzaprine HCl sublingual tablet for the treatment of major depressive disorder and acute stress reaction/acute stress disorder; TNX-1300, a double-mutant cocaine esterase for the treatment of cocaine intoxication; TNX-1500, an Fc-modified humanized monoclonal antibody to prevent kidney transplant rejection, as well as to treat autoimmune conditions; TNX-4800, a humanized monoclonal antibody for the seasonal prevention of Lyme disease; and TNX-2900, an intranasal oxytocin potentiated with magnesium for the treatment of Prader-Willi syndrome. Further, it is developing TNX-1900, an intranasal potentiated oxytocin for the treatment of binge eating disorder, adolescent obesity, and bone health in pediatric autism, and arginine-vasopressin deficiency; TNX-801, a live horsepox vaccine for the prevention of smallpox and mpox; TNX-4200, a small molecule broad-spectrum antiviral agent targeting CD45 for the treatment or prevention of viral disease; TNX-4900, a highly selective small-molecule Sigma-1 receptor antagonist for neuropathic pain; TNX-1700, a recombinant Trefoil Factor Family 2 fusion protein for the treatment of gastric and colorectal cancers; and TNX-1800 and TNX-1850, live modified horsepox vaccines for the prevention of COVID. Tonix Pharmaceuticals Holding Corp. was founded in 2007 and is based in Berkeley Heights, New Jersey.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.